| Value | ₹87.87 Cr |
|---|---|
| Execution period | Within next 15 days |
BSE filing, NSE: MAXHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹860.00
- Market cap
- ₹83,705 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 57.5×Sector 52.8×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY
Max Healthcare Institute Employee Stock Options
Max Healthcare's NRC approved 95,000 ESOPs at ₹800 exercise price under its 2022 scheme. Vesting spans 1-5 years with a 3-year post-vesting exercise window.
Other acquisition announcements
All →Rane Holdings Acquisition Worth ₹80.85 Cr
Rane Holdings completed Rs 80.85 crore further investment in joint venture ZF Lifetec Rane Automotive. Its 49% stake stays unchanged after subscribing 5,15,954 shares.
- Value
- ₹80.85 Cr
Deep Health AI India Acquisition Worth ₹19.5 Cr
Deep Health AI amended its MoU to acquire Pune agricultural land, revising consideration to Rs. 19.50 Crore. Completion is extended by one year under the revised terms.
- Value
- ₹19.50 Cr
- Execution
- Balance consideration and completion timelines extended by one year
Aeroflex Enterprises Acquisition Worth ₹31 Cr
Aeroflex Neu, a material subsidiary, approved acquiring 55% of Aerolex Cables for ₹31 Crore. The move enters wire and cable manufacturing and exporting.
- Value
- ₹31.00 Cr
Brainbees Solutions Acquisition Worth ₹18.68 Cr
Brainbees' subsidiary Globalbees acquired an additional 14.23% stake in JW Brands for INR 18.68 Crore in cash. JW Brands becomes 89.33% owned, lifting Globalbees' holding from 75.10%.
- Value
- ₹18.68 Cr
Aeroflex Neu Acquisition Worth ₹31 Cr
Aeroflex Neu will buy 55% of Aerolex Cables Private Limited for ₹31.00 Crore in cash. Further tranches will follow under pre-agreed valuation terms.
- Value
- ₹31.00 Cr
- Execution
- First tranche of 55% within 60 days of board approval; later tranches per definitive agreements
Ace Alpha Tech Acquisition
Ace Alpha Tech's board approved amalgamating with listed Share India Securities Limited, subject to approvals and NCLT sanction. Half-year results were also approved.